Editor: " Atta-ur-Rahman"

Advances in Cancer Drug Targets

Volume 1

Personal Book: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library Book: US $356
ISSN: 2451-8891
eISSN: 2213-9915 (Online)
ISBN: 978-1-60805-601-9
eISBN: 978-1-60805-474-9 (Online)
DOI: 10.2174/97816080547561130101

Introduction

Advances in Cancer Drug Targets is an e-book series that brings together recent expert reviews published on the subject with a focus on strategies for synthesizing and isolating organic compounds and elucidating the structure and nature of DNA. The reference work serves to give readers a brief yet comprehensive glance at current theory and practice behind employing chemical compounds for tackling tumor suppression, DNA site specific drug targeting and the inhibition of enzymes involved in growth control pathways. The reviews presented in this series are written by experts in pharmaceutical sciences and molecular biology. These reviews have been carefully selected to present development of new approaches to anti-cancer therapy and anti-cancer drug development. This e-book volume will be of special interest to molecular biologists and pharmaceutical scientists.

Contributors

Editor(s):
Atta-ur-Rahman
Honorary Life Fellow Kings College
University of Cambridge
Cambridge
UK




Contributor(s):
Carolina Alonso-González
Department of Physiology and Pharmacology
School of Medicine
University of Cantabria
Spain


Virginia Alvarez-García
Department of Physiology and Pharmacology
School of Medicine
University of Cantabria
Spain


Øystein Bruserud
Institute of Medicine
University of Bergen
Haukeland University Hospital
Norway


Guido Cavaletti
Department of Neuroscience and Biomedical Technologies
University of Milano-Bicocca
Italy


Justin Cidado
The Sidney Kimmel Comprehensive Cancer Center
School of Medicine
The Johns Hopkins University
USA


Samuel Cos
Department of Physiology and Pharmacology
School of Medicine
University of Cantabria
Spain


David Cosgrove
Division of Medical Oncology
The Johns Hopkins University
School of Medicine
USA


Sarah Croessmann
The Sidney Kimmel Comprehensive Cancer Center
School of Medicine
The Johns Hopkins University
USA


Elisabeth Ersvær
Institute of Medicine
University of Bergen
Norway


Greg Finn
Cancer Biology Program
Division of Hematology/Oncology
Department of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School
USA


Bjørn Tore Gjertsen
Section for Hematology
Department of Medicine
Haukeland University Hospital
Norway


Alicia González
Department of Physiology and Pharmacology
School of Medicine
University of Cantabria
Spain


John P. Gustin
The Sidney Kimmel Comprehensive Cancer Center
School of Medicine
The Johns Hopkins University
USA


Bing-Hua Jiang
Department of Pathology
Anatomy and Cell Biology
Thomas Jefferson University
USA


Astrid Olsnes Kittang
Section for Hematology
Department of Medicine
Haukeland University Hospital
Norway


Ling-Zhi Liu
Department of Pathology
Anatomy and Cell Biology
Thomas Jefferson University
USA


Kun Ping Lu
Cancer Biology Program
Division of Hematology/Oncology
Department of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School
USA


Man-Li Luo
Cancer Biology Program
Division of Hematology/Oncology
Department of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School
USA


Carlos Martínez-Campa
Department of Physiology and Pharmacology
School of Medicine
University of Cantabria
Spain


Guro Kristinv Melve
Department of Immunology and Transfusion Medicine
Haukeland University Hospital
Norway


Ben Ho Park
Department of Oncology
The Sidney Kimmel Comprehensive Cancer Center
The Johns Hopkins University
USA


Håkon Reikvam
Institute of Medicine
University of Bergen
Haukeland University Hospital
Norway


Virginia Rodriguez-Menendez
Department of Neuroscience and Biomedical Technologies
University of Milano-Bicocca
Italy


Ahmad R. Safa
Department of Pharmacology and Toxicology
Indiana University Simon Cancer Center
Indiana University School of Medicine
USA


Pooja S. Sharma
Department of Chemistry
C.S.S.S. (P.G.) College
India


Rajan Sharma
Department of Chemistry
C.S.S.S. (P.G.) College
India


Lucio Tremolizzo
Department of Neuroscience and Biomedical Technologies
University of Milano-Bicocca
Italy


Xiao Zhen Zhou
Cancer Biology Program
Division of Hematology/Oncology
Department of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School
USA




RELATED BOOKS

.Potassium Channels as a Target for Clinical Therapeutics.